Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Dietary-induced obese (DIO) mice and rats

Dietary-induced obese (DIO) mice and rats are well-established animal models of obesity that offer proven predictive validity of clinically effective weight loss drugs.

Our DIO mouse model is ready to use, therefore enabling a quick start to your study and a seamless transition from DIO induction phase to testing of novel treatments.

Key features of our DIO mouse model are:

  • Weight stable (allowing assessment of weight loss rather than inhibition of weight gain)
  • Marked adiposity (30-40% fat)
  • Moderate insulin resistance
  • Ectopic lipid deposition and liver steatosis
  • Elevated plasma lipids

Below is an example of a typical 4-week study using the DIO mouse model, which demonstrates efficacy of the clinically effective GLP-1 receptor agonist, semaglutide.

We have also developed and validated a DIO rat model using female Wistar rats allowed to develop obesity by ad libitum access to a simplified cafeteria diet, consisting of high-fat chow, ground chocolate and ground peanuts to mirror a typical calorie-dense Western diet. The DIO rat model has excellent predictive validity and is produced on demand, with a 16-week lead time.

Twice-weekly administration of semaglutide reduces body weight in the dietary-induced obese (DIO) mouse

Twice-weekly administration of semaglutide reduces cumulative daily food intake in the dietary-induced obese (DIO) mouse

 

Twice-weekly administration of semaglutide reduces total adiposity in the dietary-induced obese (DIO) mouse

 

Twice-weekly administration of semaglutide reduces liver lipid content in the dietary-induced obese (DIO) mouse

 

Twice-weekly administration of semaglutide improves glucose tolerance in the dietary-induced obese (DIO) mouse

 

Twice-weekly administration of semaglutide improves the plasma cholesterol profile in the dietary-induced obese (DIO) mouse

Studies in dietary-induced obese rats and mice are customised for each client and can include measurements of a range of different parameters.

Get in touch for more information or browse our models of metabolic disorders.

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.